Your institution may have access to this item. Find your institution then sign in to continue.
Title
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Authors
Ziegler, D; Hanefeld, M; Ruhnau, K J; Hasche, H; Lobisch, M; Schütte, K; Kerum, G; Malessa, R
Abstract
To evaluate the efficacy and safety of alpha-lipoic acid given intravenously, followed by oral treatment in type 2 diabetic patients with symptomatic polyneuropathy.